Search Results 561-570 of 16742 for Azlocillin

  1. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  2. A Study of Performing Surgery for Resectable Malignant Pleural Mesothelioma After Radiation Therapy - Mayo Clinic

    The purpose of this study is to assess the possibility, safety, and therapeutic effect of administering a short, quick course of high-dose radiation treatment ...

  3. Aminophylline (intravenous route) - Side effects & uses - Mayo Clinic

    Aminophylline injection is used together with other medicines to treat the acute symptoms of asthma, bronchitis, emphysema, and other lung diseases in a ...

  4. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...

  5. Allergic Diseases - Clinical trials

    Find open clinical trials in the Mayo Clinic Division of Allergic Diseases.

  6. A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma - Mayo Clinic

    About this study. The purpose of the dose escalation part of the study is to characterize the safety and tolerability of ALN-BCAT as monotherapy and in ...

  7. Donor-Specific Cell Free DNA Monitoring of Thoracic Allografts - Mayo Clinic

    The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.

  8. Valchlor in the Treatment of Lichen Planopilaris - Mayo Clinic

    Secondary measures of efficacy will be the mean follicular density, Physician Global assessment (PGA) score, and the Dermatology Quality of Life Index (DQLI) ...

  9. A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

    Combining amivantamab and lazertinib may lead to improved treatment outcomes through synergistic anti-EGFR activity, prevention of EGFR- or MET-based resistance ...

  10. GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...